LOGIN  |  REGISTER
Terns Pharmaceuticals
Chimerix

Alphatec to Participate in Upcoming Conferences

August 08, 2025 | Last Trade: US$14.97 0.07 0.47

CARLSBAD, Calif. / Aug 08, 2025 / Business Wire / Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences:

  • The 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 12, 2025.
  • The RBCCM Medical Supplies & Devices Virtual Symposium virtually on August 18, 2025, from 10:00am – 11:00am ET.
  • The Piper Sandler MedTech and Diagnostics West Coast Bus Tour at The Ritz Carlton Laguna Niguel in Dana Point, CA at 7:55am PT.
  • The Wells Fargo 2025 Healthcare Conference beginning on September 3, 2025, at The Encore Boston Harbor in Everett, MA, with a fireside chat at 10:30am ET.

If available, the live webcasts will be accessible on ATEC’s Investor Relations website.

Inducement Awards Granted

As an inducement material to accepting employment with the Company, and in accordance with Nasdaq Listing Rule 5635(c)(4), ATEC today announced that the independent Compensation Committee of the Board of Directors has approved aggregate grants to 9 new employees (who are not executive officers) of, collectively, 11,967 restricted stock units (“RSUs”) under the Company’s 2016 Employment Inducement Award Plan. The RSUs will vest in equal annual installments on each of the first four anniversaries of the grant date, provided that the recipient remains continuously employed by ATEC as of such vesting date. In addition, the RSUs will vest fully upon a change of control of ATEC.

About ATEC

ATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATEC’s Organic Innovation MachineTM is focused on developing new approaches that integrate seamlessly with the Company’s expanding AlphaInformatiX Platform to better inform surgery and more safely and reproducibly achieve the goals of spine surgery. ATEC’s vision is to become the Standard Bearer in Spine. For more information, visit us at www.atecspine.com.

Assertio

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page